UBS O'Connor’s Thrive Acquisition Corporation Warrant THACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,354
Closed -$6K 750
2022
Q3
$6K Sell
73,354
-7,344
-9% -$662 ﹤0.01% 933
2022
Q2
$9K Buy
+80,698
New +$14.5K ﹤0.01% 947
2022
Q1
Sell
-128,942
Closed -$62K 606
2021
Q4
$62K Buy
+128,942
New +$58.7K ﹤0.01% 890

Other funds holding THACW

UBS O'Connor's THACW Position: Q4 2022 in Review

UBS O'Connor sold out of Thrive Acquisition Corporation Warrant (THACW) in Q4 2022, closing a stake of 73,354 shares — an estimated $6K sold.

UBS O'Connor first reported a position in THACW in Q4 2021 and held it in 3 quarters. The position peaked at $62K in Q4 2021. 42 funds tracked by Wall St. Rank hold THACW as of Q4 2022.

  • UBS O'Connor reported no remaining Thrive Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 73,354 Thrive Acquisition Corporation Warrant shares in Q4 2022, an estimated $6K.
  • UBS O'Connor first reported a position in Thrive Acquisition Corporation Warrant in Q4 2021 and held it in 3 quarters.
  • UBS O'Connor's Thrive Acquisition Corporation Warrant position peaked at $62K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Warrant as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.